AbbVie
ABBV
#25
Rank
S$497.31 B
Marketcap
$281.13
Share price
2.06%
Change (1 day)
15.40%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: S$497.31 Billion

As of April 2025 AbbVie has a market cap of S$497.31 Billion. This makes AbbVie the world's 25th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$497.31 B16.31%
2024S$427.58 B18.33%
2023S$361.35 B-5.69%
2022S$383.14 B18.4%
2021S$323.60 B29.31%
2020S$250.26 B41.76%
2019S$176.53 B-5.22%
2018S$186.25 B-9.8%
2017S$206.49 B40.21%
2016S$147.28 B9.18%
2015S$134.90 B-1.96%
2014S$137.60 B29.56%
2013S$106.20 B60.91%
2012S$66.00 B

End of Day market cap according to different sources

On Mar 31st, 2025 the market cap of AbbVie was reported to be:

S$497.31 Billion
by Yahoo Finance info icon info icon
S$497.31 Billion
by CompaniesMarketCap info icon info icon
S$496.43 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$192.83 B-61.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$166.51 B-66.52%๐Ÿ‡บ๐Ÿ‡ธ USA
S$995.14 B 100.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$224.56 B-54.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$187.42 B-62.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$26.87 B-94.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$105.65 B-78.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$307.51 B-38.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$14.79 B-97.02%๐Ÿ‡บ๐Ÿ‡ธ USA